Odapt
Odapt is developing a personalized, 3D-printed wafer for ostomy bags. Using a simple 3D scan of the patient's stoma and surrounding skin, the company creates a custom-fit, reusable silicone wafer that prevents leaks, reduces skin complications, and improves user comfort and confidence.
- CEO / Founder
- Ivana Llobet
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- $75K
- Latest Round
- Pre-Seed
- Key Investors
- mHUB
Technology & Products
Key Products
["Custom 3D-printed silicone wafer for ostomy bags"]
Technological Advantage
The technology allows for a rapid, on-demand manufacturing process that is adaptable to patient needs. The business advantage lies in addressing a major unmet need (leakage and discomfort) in a large market, with a product that enhances user loyalty through personalization and improved outcomes. The reusable nature of the product also introduces a sustainability angle.
Differentiation
Value Proposition
To provide a leak-proof, comfortable, and personalized ostomy care solution that significantly improves the quality of life for users, while also being more sustainable than current disposable options.
How They Differentiate
Odapt differentiates itself from large, established competitors by offering a fully personalized product. While competitors produce a range of standard-sized disposable products, Odapt creates a unique, reusable device for each user, directly addressing the primary problems of poor fit and leakage.
Market & Competition
Target Customers
Patients with stomas (ostomates) who use ostomy bags, and healthcare providers (hospitals, clinics) that serve them.
Industry Verticals
["Healthcare","Medical Devices"]
Competitors
Coloplast; Hollister Incorporated; ConvaTec
Growth & Milestones
Growth Metrics
Winner of the Formnext 2023 Start-up Challenge; Selected for the mHUB + Baxter MedTech Accelerator 2024 cohort. Currently building a waiting list for their first product trial.
Major Milestones
["Founded in 2022.","Developed a prototype and proprietary process for custom 3D-printed ostomy wafers.","Won the Formnext Start-up Challenge in November 2023.","CEO accepted into the prestigious Stanford Biodesign Innovation Fellowship in 2023.","Selected for the EIT Health CRAASH Barcelona program.","Selected for the mHUB MedTech Accelerator and received initial investment in May 2024."]
Notable Customers
Not yet commercially available; currently in the trial phase.